We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$5.97M
2
FISV
Fiserv Inc
FISV
+$5.03M
3
GPC icon
Genuine Parts
GPC
+$4.22M
4
TRI icon
Thomson Reuters
TRI
+$4.1M
5
VGR
Vector Group Ltd.
VGR
+$4.09M

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IZM icon
1576
ICZOOM Group
IZM
$3.04M
$20K ﹤0.01%
+10,497
New +$80.6K
ACET icon
1577
Adicet Bio
ACET
$74.7M
$18K ﹤0.01%
+938
New +$25.1K
AA icon
1578
Alcoa
AA
$13.2B
– –
-17,624
Closed -$596K
ABBV icon
1579
AbbVie
ABBV
$435B
– –
-2,965
Closed -$540K
ABOS icon
1580
Acumen Pharmaceuticals
ABOS
$176M
– –
-25,370
Closed -$103K
ACHR icon
1581
Archer Aviation
ACHR
$4.26B
– –
-68,578
Closed -$317K
ACIW icon
1582
ACI Worldwide
ACIW
$5.46B
– –
-25,487
Closed -$846K
ADAP
1583
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-370,179
Closed -$585K
ADNT icon
1584
Adient
ADNT
$1.5B
– –
-9,408
Closed -$310K
ADV icon
1585
Advantage Solutions
ADV
$361M
– –
-857
Closed -$93K
AEIS icon
1586
Advanced Energy
AEIS
$13B
– –
-7,835
Closed -$799K
AFL icon
1587
Aflac
AFL
$63.4B
– –
-7,348
Closed -$631K
AFRM icon
1588
Affirm
AFRM
$25.2B
– –
-20,946
Closed -$780K
AGEN
1589
Agenus
AGEN
$290M
– –
-63,550
Closed -$737K
AGIO icon
1590
Agios Pharmaceuticals
AGIO
$1.93B
– –
-30,853
Closed -$902K
AKAM icon
1591
Akamai
AKAM
$16.1B
– –
-1,866
Closed -$203K
AKRO
1592
DELISTED
Akero Therapeutics
AKRO
– –
-11,116
Closed -$281K
AL
1593
DELISTED
Air Lease Corp
AL
– –
-18,776
Closed -$966K
ALSN icon
1594
Allison Transmission
ALSN
$9.82B
– –
-15,143
Closed -$1.23M
ALXO icon
1595
ALX Oncology
ALXO
$283M
– –
-10,289
Closed -$115K
AMLX icon
1596
Amylyx Pharmaceuticals
AMLX
$2.54B
– –
-79,652
Closed -$226K
AMP icon
1597
Ameriprise Financial
AMP
$48.8B
– –
-841
Closed -$369K
AMPX icon
1598
Amprius Technologies
AMPX
$1.68B
– –
-28,579
Closed -$76K
AMTX icon
1599
Aemetis
AMTX
$121M
– –
-33,238
Closed -$199K
AMWL icon
1600
American Well
AMWL
$230M
– –
-3,503
Closed -$57K
62 63
64
65 66

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.